Bio-Synthesis, Inc.
Lewisville, TX Doing business as Dnaexam
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325199 All Other Basic Organic Chemical Manufacturing
- 325411 Medicinal and Botanical Manufacturing
- 325412 Pharmaceutical Preparation Manufacturing
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- 800 Mario Ct, Lewisville, TX 75057, USA
- Website
- biosyn.com
- Founded
- 1984
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $10,585 |
| FY2024 | $0 |
| FY2023 | $10,950 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Synergistic vaccine adjuvants that stimulate both innate and adaptive immunities | National Institutes of Health | $590,207 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Genscript Probio USA Inc. | Pennington, NJ | 325414 Biological Product (except Diagnostic) Manufacturing |
| Trilink Biotechnologies, LLC | San Diego, CA | 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing |
| Creative Enzymes | Shirley, NY | 541713 Research and Development in Nanotechnology |
| Peptide 2.0 Inc. | Chantilly, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Medchemexpress LLC | South Brunswick Township, NJ | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Bio-Synthesis, Inc., operating under the trade name Dnaexam, is a Hispanic American-owned corporate entity registered in SAM.gov since 2002, specializing in advanced biological research materials and custom synthesis services. Located in Lewisville, Texas, the company is structured as a for-profit, Subchapter S Corporation that manufactures scientific goods with a focus on specialized molecular and genetic research products. As a manufacturer of goods, Bio-Synthesis, Inc. demonstrates expertise in producing complex biological materials for federal research institutions, with a particular emphasis on peptide, RNA, and nucleic acid synthesis.
The company has secured multiple federal contract awards from prominent health-related research agencies, including the National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, and National Institute on Drug Abuse. Their federal contract awards reveal a specialized capability in producing custom research materials, such as stapled NIX-derived peptides with derivatized N-termini, custom RNA synthesis, and RNA oligos specifically supporting COVID-19 research. The contract awards, ranging from $10,585 to $28,135, are structured as purchase orders with no specific set-aside designations. These contracts demonstrate Bio-Synthesis, Inc.'s technical capacity to deliver precise, high-quality molecular research materials that support critical scientific investigations across various biomedical research domains, with a notable recent contribution to pandemic-related research efforts.
SBA capabilities narrative
Core Services
Oligonucleotide synthesis
Peptide synthesis
Antibody production
Bio-conjugation services
Organic synthesis
Molecular Biology Services (Cloning, Protein Expression and SNP Genotyping)
Analytical services (MS, HPLC, GC, AAA, Sequencing, Etc.)
Complex oligonucleotide synthesis and modifications
o Complex oligonucleotide constructs with multiple labels
o Chemical DNA (up to 300 bases), RNA (up to 200 bases)
o Ultra long RNA Transcripts >3000 nucleotides
o Multi-gram DNA and RNA oligomer production
o Oligonucleotide-biomolecule or small molecule conjugates (siRNA-peptide conjugates, DNA-peptides, RNA-peptide conjugates)
o Exclusive provider of a novel nucleic acid analog, namely BNA (bridged nucleic acid)
Complex peptide synthesis and modifications
o Custom peptide synthesis up to 150 amino acids
o Large volume peptide manufacturing facility
o Large scale peptide production
o Peptide-biomolecule or small molecule conjugates
Antibody and protein engineering
Quick answers
Is Bio-Synthesis, Inc. registered in SAM.gov?
Yes. Bio-Synthesis, Inc.'s SAM.gov registration is active through September 18, 2027.
What is Bio-Synthesis, Inc.'s CAGE code?
Bio-Synthesis, Inc.'s CAGE code is 1EKY7, and its Unique Entity ID (UEI) is MWJBT69QFLH4.
How much has Bio-Synthesis, Inc. received in federal contracts?
Federal contracts obligated $10,585 to Bio-Synthesis, Inc. in fiscal year 2025 and $21,535 in fiscal years 2023 through 2027.
What is Bio-Synthesis, Inc.'s most recent federal award?
Bio-Synthesis, Inc.'s most recent federal contract award is [25-008602] the laboratory of structural biophysics requires the stapled NIX-derived peptides with derivatized… (75N92025P00180), from National Heart Lung and Blood Institute (NIH), on April 24, 2025.
On GovTribe
See Bio-Synthesis, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors